Proxodolol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameProxodolol
Drug Alias Name普索洛尔
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonistsAlpha adrenergic receptor antagonists
TargetsBeta adrenergic receptorsAlpha adrenergic receptor
Therapy Area/IndicationsHypertensionAngina PectorisGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCenter For Chemistry Of Drugs
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter For Chemistry Of Drugs
Active IndicationsN/A
Inactive IndicationsHypertensionAngina PectorisGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A